The drugs include Darunavir, Cobicistat, Emtricitabine, and Tenofovir Alafenamide tablets and the company is the exclusive ...

Mumbai: Global pharma major Lupin Limited has announced that it has received tentative approval from the United States Food ...

Drug maker Lupin on Monday said it has received approval from the US health regulator to market a generic medication for Human Immunodeficiency Virus. The company has received tentative approval from ...

The Indian Pharmaceuticals Market continued to deliver healthy growth at 8.7% year-on-year in January 2025, against 7.7% year ...

Lupin is an innovation led Transnational Pharmaceutical Company producing developing and marketing a wide range of branded & generic formulations biotechnology products and active pharmaceutical ...

The main industry in which Lupin Ltd operates is Pharmaceuticals - Indian - Bulk Drugs & Formln. Auditor/Auditors for Lupin Ltd is/are B S R & Co LLP. In the main management, M D Gupta is chairman ...

Indian pharma stocks experienced heavy selling on February 10, influenced by weak earnings and concerns over possible U.S.

The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.

The world is currently grappling with what US President Trump will do or undo on the tariffs front. And markets will have to deal with this issue till the politics of one-upmanship is settled. As an ...

Report with market evolution powered by AI - The global antibiotics market size is estimated to grow by USD 18.22 billion ...

Biovet, a subsidiary of the Bharat Biotech Group, has received approval from the CDSCO for its innovative LSD vaccine, ...